NCT00054574 2020-08-03
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
6 trialsNCT01916109 2016-02-12
Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
NCT01374789 2015-06-03
PURO
WiSP Wissenschaftlicher Service Pharma GmbH
Phase 2 Terminated
NCT00425035 2013-05-13
Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2
Amgen
Phase 2 Completed
NCT00425204 2008-09-15
Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment
Amgen
Phase 2 Completed
NCT00061126 2005-06-24
ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body
Abgenix
Phase 2 Completed